Grade: Pharmaceutical Grade

Factory Location: Quanzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Sample Provided: no

Payment Terms: L/C

Eltrombopag is an oral thrombopoietin receptor agonist (TPO-RA) used to treat thrombocytopenia. Common side effects include headache, nasopharyngitis, nausea, vomiting, diarrhea, etc.